Orchid Capital Ltd 26-Oct-05 Has entered into an Investment Agreement with the Singapore-based pharmaceutical group, Xingling International Pte Ltd. Orchid will invest S$250,000 (circa £84,500 or A$197,000) to acquire a majority stake (51%) in the Company, subject to due diligence and shareholder approval.